http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108276373-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30 |
| filingDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108276373-B |
| titleOfInvention | Flavonoid compound and application thereof in anti-cancer drugs |
| abstract | The invention provides a flavonoid compound and application thereof in anti-cancer drugs, wherein the flavonoid compound has a structure shown in the following general formula (I): wherein m is 1-10; r 1 And R 2 Independently selected from hydrogen, hydroxy, and aryl, heteroaryl, unsubstituted or substituted with one or more first substituents; x is selected from hydrogen, hydroxyl, nitro, halogen, amino or cyano; r 3 Selected from hydrogen, hydroxy, -O (CH) 2 ) n N(R 4 R 5 ) Wherein n is 2 to 10, R 4 And R 5 Are independently selected from hydrogen, C unsubstituted or substituted by one or more second substituents 1 ‑C 10 Alkyl radical, C 2 ‑C 12 Alkenyl radical, C 1 ‑C 10 Haloalkyl, C 2 ‑C 12 Haloalkenyl, C 2 ‑C 14 Heteroalkyl group, C 2 ‑C 12 Alkenyloxy radical, C 1 ‑C 6 Alkynyloxy, amino, C 1 ‑C 10 Alkylamino radical, C 1 ‑C 10 Aminoalkyl radical, C 1 ‑C 10 Alkylcarbonyl group, C 1 ‑C 10 Alkoxycarbonyl, C 1 ‑C 10 Alkylaminocarbonyl radical, C 1 ‑C 10 Alkylcarbonyl or C 5 ‑C 12 An arylcarbonyl group. |
| priorityDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.